Women's Health

The drug is approved as a diagnostic tool to help identify cancerous lesions during surgery, which is normally difficult to detect. The drug is administered intravenously prior to surgery.

The FDA has approved a new option for the treatment of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.

The FDA has approved the first drug for the treatment of generalized hypoactive sexual desire disorder in premenopausal women.

This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in June and July, including the first over-the-counter, nonprescription daily oral contraceptive, the first monoclonal...

The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...